155 related articles for article (PubMed ID: 860726)
41. Mesangiocapillary glomerulonephritis and persistent hypocomplementemia.
Cameron JS; Ogg CS; Turner DR; Weller RO; White RH; Glasgow EF; Peters DK; Martin A
Perspect Nephrol Hypertens; 1973; 1 Pt 1():541-56. PubMed ID: 4220250
[No Abstract] [Full Text] [Related]
42. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis.
Cameron JS; Turner DR; Heaton J; Williams DG; Ogg CS; Chantler C; Haycock GB; Hicks J
Am J Med; 1983 Feb; 74(2):175-92. PubMed ID: 6337487
[TBL] [Abstract][Full Text] [Related]
43. Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common pathogenic mechanism.
Corvillo F; López-Trascasa M
Nefrologia (Engl Ed); 2018; 38(3):258-266. PubMed ID: 29279276
[TBL] [Abstract][Full Text] [Related]
44. Persistent hypocomplementemia in membrano-proliferative glomerulonephritis.
J Assoc Physicians India; 1978 Dec; 26(12):1167-70. PubMed ID: 752007
[No Abstract] [Full Text] [Related]
45. Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.
Vallota EH; Forristal J; Spitzer RE; Davis NC; West CD
J Exp Med; 1970 Jun; 131(6):1306-24. PubMed ID: 4192571
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of C3 allotypes in patients with nephritic factor.
Finn JE; Mathieson PW
Clin Exp Immunol; 1993 Mar; 91(3):410-4. PubMed ID: 8443964
[TBL] [Abstract][Full Text] [Related]
47. Partial lipodystrophy and hypocomplementaemic nephritis.
Thompson RA; White RH
Lancet; 1973 Sep; 2(7830):679. PubMed ID: 4125651
[No Abstract] [Full Text] [Related]
48. [Morphological varieties of membranoproliferative glomerulonephritis].
Imbasciati E; Tarantino A; Ponticelli C; Giani M; Bardare M; Gaboardi F
Minerva Nefrol; 1981; 28(3):415-9. PubMed ID: 7329619
[No Abstract] [Full Text] [Related]
49. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
[No Abstract] [Full Text] [Related]
50. Idiopathic rapidly progressive glomerulonephritis with C3 nephritic factor and hypocomplementemia.
Davis CA; McAdams AJ; Wyatt RJ; Forristal J; McEnery PT; West CD
J Pediatr; 1979 Apr; 94(4):559-63. PubMed ID: 372512
[TBL] [Abstract][Full Text] [Related]
51. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).
Owen KR; Donohoe M; Ellard S; Clarke TJ; Nicholls AJ; Hattersley AT; Bingham C
Nephron Clin Pract; 2004; 96(2):c35-8. PubMed ID: 14988595
[TBL] [Abstract][Full Text] [Related]
52. Nephritic factor: Description of a new quantitative assay and findings in glomerulonephritis.
Border WA; Wilson CB; Götze O
Kidney Int; 1976 Oct; 10(4):311-8. PubMed ID: 62864
[TBL] [Abstract][Full Text] [Related]
53. The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of two cases.
Wayte J; Bird G; Wilkinson JD
Clin Exp Dermatol; 1996 Mar; 21(2):131-4. PubMed ID: 8759201
[TBL] [Abstract][Full Text] [Related]
54. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
Yamada A; Ohi H; Okano K; Watanabe S; Seki M; Hatano M; Koitabashi Y
J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
[TBL] [Abstract][Full Text] [Related]
55. C3 nephritic factor and mesangiocapillary glomerulonephritis.
Williams DG
Pediatr Nephrol; 1997 Feb; 11(1):96-8. PubMed ID: 9035182
[TBL] [Abstract][Full Text] [Related]
56. Editorial: Glomerulonephritis, complement and C3NeF.
Fearon DT
N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
[No Abstract] [Full Text] [Related]
57. The C3 nephritic factor (C3NeF) and the heat labile complement inactivator (HLCI) in chronic hypocomplementemic mesangioproliferative glomerulonephritis.
Berthoux FC; Carpenter CB; Traeger J; Merrill JP
Adv Nephrol Necker Hosp; 1974; 4():91-108. PubMed ID: 4220002
[No Abstract] [Full Text] [Related]
58. [Barraquer and Simons lipodystrophy. Complement anomalies and cutaneous leukocytoclasic vasculitis].
Perrot H; Delaup JP; Chouvet B
Ann Dermatol Venereol; 1987; 114(9):1083-91. PubMed ID: 3434945
[TBL] [Abstract][Full Text] [Related]
59. Studies of serum complement in the hypocomplementaemic nephritides.
Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
[TBL] [Abstract][Full Text] [Related]
60. [Partial lipodystrophy with osteomyelitis].
Böhles H; Kövary PM
Z Hautkr; 1982 Jan; 57(2):91-100. PubMed ID: 7072309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
